I agree as well.
jb
Date: Sat, 5 May 2007 05:35:20 -0400
From: William Bug <[EMAIL PROTECTED]>
To: public-semweb-lifesci hcls
Subject: Re: SfN meeting submission
Quoting William Bug <[EMAIL PROTECTED]>:
> I agree completely, Kei.
>
> Don - do you want me to se
L PROTECTED] <mailto:[EMAIL PROTECTED]> wrote:
hi don,
Works for me as well, and I'll be glad to help anyway I can.
thanks,
jb
Date: Thu, 3 May 2007 17:00:09 -0400 From: William Bug
<[EMAIL PROTECTED] <mailto:[EMAIL PROTECTED]>> To:
public-semweb-lifesci hcls <ma
for me as well, and I'll be glad to help anyway I can.
thanks,
jb
Date: Thu, 3 May 2007 17:00:09 -0400
From: William Bug <[EMAIL PROTECTED]>
To: public-semweb-lifesci hcls
Subject: Re: SfN meeting submission
Quoting William Bug <[EMAIL PROTECTED]>:
Hi Don,
This
hi don,
Works for me as well, and I'll be glad to help anyway I can.
thanks,
jb
Date: Thu, 3 May 2007 17:00:09 -0400
From: William Bug <[EMAIL PROTECTED]>
To: public-semweb-lifesci hcls
Subject: Re: SfN meeting submission
Quoting William Bug <[EMAIL PROTECTED]>:
&g
fesci hcls
Sent: Thursday, May 03, 2007 2:00 PM
Subject: Re: SfN meeting submission
Hi Don,
This works for me.
In regards to the suggestion Mark made, I think some of his suggestions sound
very practical. I'd be glad to participate - or not - depending on the need
and intend
;
Cc: "'public-semweb-lifesci hcls'"
Sent: Thursday, May 03, 2007 10:06 AM
Subject: RE: SfN meeting submission
Here's my proposal:
I write a quick rough draft and send a copy to all interested parties.
People actually contributing to the writing should mostly be neurosc
Sent: Thursday, May 03, 2007 12:19 PM
To: William Bug
Cc: public-semweb-lifesci hcls
Subject: Re: SfN meeting submission
Hi Bill et al.,
I agree that it's important to make our SW/Neuro demo visible to the
neuroscience community. For example, I have asked Gordon Shepherd (PI of
SenseLab) t
Hi Bill et al.,
I agree that it's important to make our SW/Neuro demo visible to the
neuroscience community. For example, I have asked Gordon Shepherd (PI of
SenseLab) to look at the AD use case written by June, Gwen, et al to see
if any comments/suggestions can be made. It would be great if
Hi Don, Matthias, John, Kei, et al.,
I too would like to contribute to an SfN abstract in this context.
I believe given the domain HCLS IG is covering - neurodegenerative
disease - despite the lack of a full, refereed article, this is a
very important venue in which to present, in order to h
Hi Matthias,
That'd be great! SfN abstracts are brief (max. 2300 characters including
punctuation!) so focusing on the value to neuroscientists sounds like the
right course.
Abstract may be presented or posters. Slide presentations are kept very
brief and there is so much going on most people wo
10 matches
Mail list logo
